|
|
|
Corporate Profile: Ibex Technologies
| Summary: |
Ibex Technologies is focused on the commercialization of recombinant high-purity proprietary enzymes (heparinases and chondroitinases) from Flavobacterium heparinum as well as arthritis assays which are used for research purposes.
|
| Address (HQ): |
5485 Pare Street
Suite 100
Montreal, QC H4P 1P7
Canada |
| Phone #'s (HQ): |
| Main |
(514) 344-4004 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(514) 344-8827 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| IBT.V |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
